Issue 25, 2021

A 2-pyridone modified zinc phthalocyanine with three-in-one multiple functions for photodynamic therapy

Abstract

A 2-pyridone modified zinc phthalocyanine (denoted ZnPc-PYR) achieves a one stone for three birds outcome in the photodynamic therapy (PDT) treatment of cancer. ZnPc-PYR can be excited by both 665 and 808 nm light to treat superficial and deep tumors, store and slowly release singlet oxygen (1O2) to improve its utilization and downregulate the HIF-1 (hypoxia-inducible factor 1) expression level to enhance the tumor cell's sensitivity to PDT treatment under hypoxic conditions.

Graphical abstract: A 2-pyridone modified zinc phthalocyanine with three-in-one multiple functions for photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
03 Feb 2021
Accepted
12 Feb 2021
First published
13 Feb 2021

Chem. Commun., 2021,57, 3127-3130

A 2-pyridone modified zinc phthalocyanine with three-in-one multiple functions for photodynamic therapy

Y. Li, C. Wang, L. Zhou and S. Wei, Chem. Commun., 2021, 57, 3127 DOI: 10.1039/D1CC00645B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements